Diabetogenic effect of statins: a double-edged sword?

Diabetes Metab J · 2013 · PMC3881325 · PMID 24404512

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Among them, the TNT and IDEAL trials showed a trend toward an increase in new-onset diabetes for the atorvastatin 80 mg group compared with atorvastatin 10 mg (HR, 1.10; 95% CI, 0.94 to 1.29) or simvastatin 20 mg (HR, 1.19; 95% CI, 0.98 to 1.43).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.